Miguel A Cruz Selected Research

platelet type Von Willebrand disease

6/2005	Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.
12/2003	Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel A Cruz Research Topics

Disease

12	Thrombosis (Thrombus) 01/2021 - 07/2009
7	Vascular System Injuries 01/2020 - 07/2002
4	Hemorrhage 03/2022 - 06/2005
4	Inflammation (Inflammations) 01/2020 - 07/2013
4	von Willebrand Diseases (von Willebrand's Disease) 01/2020 - 07/2009
4	Thrombotic Thrombocytopenic Purpura 10/2015 - 06/2002
3	Sepsis (Septicemia) 01/2022 - 07/2013
3	Critical Illness (Critically Ill) 01/2022 - 05/2015
3	Disseminated Intravascular Coagulation 01/2020 - 05/2015
3	Hemolysis 01/2018 - 11/2015
3	Thrombotic Microangiopathies 10/2015 - 01/2013
2	COVID-19 01/2022 - 01/2021
2	Endotoxemia 01/2020 - 05/2015
2	Type 2 von Willebrand Disease 01/2020 - 09/2008
2	Thrombocytopenia (Thrombopenia) 10/2015 - 12/2003
2	Hemolytic-Uremic Syndrome 10/2015 - 11/2013
2	Lymphoma (Lymphomas) 07/2013 - 09/2002
2	platelet type Von Willebrand disease 06/2005 - 12/2003
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018
1	Ischemic Stroke 10/2018
1	Stroke (Strokes) 10/2018
1	Multiple Organ Failure (MODS) 10/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2014
1	Infections 02/2014
1	ST Elevation Myocardial Infarction 11/2013
1	Diarrhea 11/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Atypical Hemolytic Uremic Syndrome 01/2013
1	Rupture 01/2010
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2009
1	Neoplasms (Cancer) 10/2004
1	Hodgkin Disease (Hodgkin's Disease) 05/2004
1	Purpura 12/2003

Drug/Important Bio-Agent (IBA)

19	von Willebrand FactorIBA 03/2022 - 06/2002
6	Glycoproteins (Glycoprotein)IBA 01/2020 - 02/2007
5	FibrinIBA 01/2022 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2004
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2018
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 05/2015
2	Platelet Membrane GlycoproteinsIBA 01/2021 - 09/2008
2	Hemostatics (Antihemorrhagics)IBA 01/2020 - 11/2013
2	Fibrinogen (Factor I)FDA Link 01/2018 - 12/2009
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 12/2015
2	thiamine triphosphorate (TTP)IBA 10/2015 - 12/2003
2	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 12/2011 - 07/2002
2	Biological ProductsIBA 08/2010 - 09/2002
2	Metalloproteases (Metalloproteinases)IBA 12/2003 - 08/2003
1	BuffersIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	P-SelectinIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	VimentinIBA 10/2018
1	HaptoglobinsIBA 01/2018
1	HemopexinIBA 01/2018
1	estropipate (Ogen)FDA LinkGeneric 01/2018
1	Protein Kinases (Protein Kinase)IBA 12/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2016
1	IntegrinsIBA 12/2016
1	CollagenIBA 09/2015
1	N 30IBA 11/2013
1	oxidized low density lipoproteinIBA 11/2013
1	Shiga Toxin (Shigella Toxin)IBA 11/2013
1	ParaffinIBA 07/2013
1	MicroRNAs (MicroRNA)IBA 07/2013
1	Histones (Histone)IBA 07/2013
1	Blood Proteins (Serum Proteins)IBA 01/2013
1	Complement Factor H (Factor H)IBA 01/2013
1	Thrombin FDA Link 12/2009
1	Coloring Agents (Dyes)IBA 12/2009
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 12/2009
1	Amino Acids FDA Link 06/2005
1	Messenger RNA (mRNA)IBA 10/2004
1	DisulfidesIBA 12/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 05/2004
1	Heart-Assist Devices 03/2022
1	Extracorporeal Membrane Oxygenation 11/2015